Single dose of EDIT-401 achieved ~90% or greater mean reductions in LDL-C, Lp(a), and ApoB in non-human primatesData reinforce differentiated ...

A new study shows apolipoprotein B (apoB) and non-high-density-lipoprotein (non-HDL) cholesterol — but not low-density-lipoprotein (LDL) cholesterol — are associated with increased risk for all-cause ...

LDL-C is considered to be the major lipid risk factor and the main target of lipid-lowering therapy. Nevertheless, as all potentially atherogenic lipoprotein particles contain only one molecule of ...

ApoB is emerging as a crucial piece of the heart health puzzle, even as sophisticated machines whir and beep with promises of precise diagnoses in the gleaming corridors of modern medicine. As ...

image: In a new study presented at the 2023 American College of Cardiology annual Scientific Sessions in New Orleans, researchers from Intermountain Health found that ApoB testing may help identify ...

The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for many Americans, according to a study led by UT Southwestern Medical Center researchers and ...

Excess apolipoprotein B (apoB) levels—in amounts higher than expected based on LDL cholesterol levels alone—provide important clinical information about the risk of future cardiovascular disease not ...

There’s a more accurate way of measuring who’s at risk for cholesterol-related health issues. So why don’t more doctors use it?